MX2016008546A - Reduccion de queloides utilizando alantoina topica. - Google Patents

Reduccion de queloides utilizando alantoina topica.

Info

Publication number
MX2016008546A
MX2016008546A MX2016008546A MX2016008546A MX2016008546A MX 2016008546 A MX2016008546 A MX 2016008546A MX 2016008546 A MX2016008546 A MX 2016008546A MX 2016008546 A MX2016008546 A MX 2016008546A MX 2016008546 A MX2016008546 A MX 2016008546A
Authority
MX
Mexico
Prior art keywords
allantoin
topical
keloid formation
keloid
patient
Prior art date
Application number
MX2016008546A
Other languages
English (en)
Inventor
Ryan Robert
Original Assignee
Scioderm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scioderm Inc filed Critical Scioderm Inc
Publication of MX2016008546A publication Critical patent/MX2016008546A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Las modalidades de la presente invención proporcionan formulaciones y métodos para el tratamiento o la reducción de la formación de queloides utilizando alantoína en una cantidad de aproximadamente 3.0% a aproximadamente 15.0% en peso.
MX2016008546A 2013-12-27 2014-12-23 Reduccion de queloides utilizando alantoina topica. MX2016008546A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361921231P 2013-12-27 2013-12-27
PCT/US2014/072206 WO2015100348A1 (en) 2013-12-27 2014-12-23 Keloid reduction using topical allantoin

Publications (1)

Publication Number Publication Date
MX2016008546A true MX2016008546A (es) 2017-07-13

Family

ID=53479662

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008546A MX2016008546A (es) 2013-12-27 2014-12-23 Reduccion de queloides utilizando alantoina topica.

Country Status (7)

Country Link
US (1) US20160338997A1 (es)
EP (1) EP3086786A4 (es)
JP (1) JP2017501232A (es)
AU (1) AU2014369952A1 (es)
CA (1) CA2935152A1 (es)
MX (1) MX2016008546A (es)
WO (1) WO2015100348A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3089729A4 (en) * 2014-01-03 2017-06-14 Scioderm Inc. Allantoin compositions for treating inflammatory skin conditions
WO2019046678A1 (en) * 2017-09-01 2019-03-07 Excel Med, Llc PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CHOLOIDS AND USES THEREOF
WO2020247532A1 (en) 2019-06-03 2020-12-10 Cooler Heads Care, Inc. Cooling cap assembly and cooling unit

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2124295A (en) * 1935-11-09 1938-07-19 Nat Drug Co Allantoin ointment
IL94806A0 (en) * 1990-06-20 1991-04-15 Ernest Bar On Pharmaceutical preparation containing thiol derivatives together with other active compounds
US20020055531A1 (en) * 1999-07-23 2002-05-09 Elliott Farber Methods for treatment of inflammatory diseases
US20060134149A1 (en) * 1999-07-23 2006-06-22 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US6531500B2 (en) * 1999-07-23 2003-03-11 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US6281236B1 (en) * 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
US6416772B1 (en) * 2001-01-12 2002-07-09 H. Wayne Van Engelen Topical dermal anaesthetic
AU2003277424A1 (en) * 2002-10-17 2004-05-04 New York University Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil
US20050276766A1 (en) * 2003-10-01 2005-12-15 Skin Biology, Inc. Methods and compositions for increasing skin remodeling
JP2005298460A (ja) * 2004-04-16 2005-10-27 Hatsuyo Ohito 外皮用剤及びその製造方法
FR2894820B1 (fr) * 2005-12-15 2008-02-29 Galderma Res & Dev Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
EP3089729A4 (en) * 2014-01-03 2017-06-14 Scioderm Inc. Allantoin compositions for treating inflammatory skin conditions
EP3104858A4 (en) * 2014-02-14 2017-07-26 Scioderm Inc. Methods for treating burns using allantoin

Also Published As

Publication number Publication date
EP3086786A1 (en) 2016-11-02
WO2015100348A1 (en) 2015-07-02
EP3086786A4 (en) 2017-06-14
WO2015100348A8 (en) 2016-05-06
AU2014369952A1 (en) 2016-07-14
US20160338997A1 (en) 2016-11-24
JP2017501232A (ja) 2017-01-12
CA2935152A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
MX2020012595A (es) Composiciones farmaceuticas topicas.
MX2016009666A (es) Suministro topico de composiciones para la piel que tienen ph bajo.
NZ601195A (en) Topical transdermal dexmedetomidine compositions and methods of use thereof
WO2012143576A3 (en) Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
MX2014008021A (es) Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
MY192033A (en) Method of dosing and use of soft anticholinergic esters
MX344787B (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
MX366076B (es) Vitamina d3 y analogos de la misma para tratar alopecia.
WO2012050831A3 (en) Combination treatment for dermatological conditions
WO2014011750A8 (en) Laquinimod formulations without alkalizing agent
MX2020006309A (es) Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.
MX2012013642A (es) Composiciones farmaceuticas topicas que comprenden furoato de mometasona.
MX2016008546A (es) Reduccion de queloides utilizando alantoina topica.
MX2016016400A (es) Formulaciones de oximetazolina estabilizadas y sus usos.
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
SG10201908690WA (en) Novel method of use and compositions
MX2013012038A (es) Combinacion de carotenoide, fitoestrogeno y vitamina c para la humectacion de la piel.
GEP201606551B (en) Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
NZ703176A (en) Stable pexiganan formulation
MX2018013477A (es) Acidos carboxilicos para tratar/prevenir una enfermedad de la piel.
SG11201903834XA (en) Medical skin external preparation
UA109944U (uk) Фармацевтична композиція для зниження рівня n-оксиду триметиламіну
MX2018013474A (es) Acidos carboxilicos para aplicacion en la primera infancia.
SG11201808241WA (en) Composition for skin moisturization or skin whitening, containing pentacyclic triterpene caffeic acid esters